Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 1
2014 1
2015 1
2016 1
2017 4
2018 1
2019 1
2020 2
2021 6
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
AIRO Breast Cancer Group Best Clinical Practice 2022 Update.
Ciabattoni A, Gregucci F, De Rose F, Falivene S, Fozza A, Daidone A, Morra A, Smaniotto D, Barbara R, Lozza L, Vidali C, Borghesi S, Palumbo I, Huscher A, Perrucci E, Baldissera A, Tolento G, Rovea P, Franco P, De Santis MC, Grazia AD, Marino L, Meduri B, Cucciarelli F, Aristei C, Bertoni F, Guenzi M, Leonardi MC, Livi L, Nardone L, De Felice F, Rosetto ME, Mazzuoli L, Anselmo P, Arcidiacono F, Barbarino R, Martinetti M, Pasinetti N, Desideri I, Marazzi F, Ivaldi G, Bonzano E, Cavallari M, Cerreta V, Fusco V, Sarno L, Bonanni A, Mangiacotti MG, Prisco A, Buonfrate G, Andrulli D, Fontana A, Bagnoli R, Marinelli L, Reverberi C, Scalabrino G, Corazzi F, Doino D, Di Genesio-Pagliuca M, Lazzari M, Mascioni F, Pace MP, Mazza M, Vitucci P, Spera A, Macchia G, Boccardi M, Evangelista G, Sola B, La Porta MR, Fiorentino A, Levra NG, Ippolito E, Silipigni S, Osti MF, Mignogna M, Alessandro M, Ursini LA, Nuzzo M, Meattini I, D'Ermo G. Ciabattoni A, et al. Among authors: fozza a. Tumori. 2022 Jul;108(2_suppl):1-144. doi: 10.1177/03008916221088885. Tumori. 2022. PMID: 36112842
Technological advancements and future perspectives in breast cancer radiation therapy.
Fozza A, De Rose F, De Santis MC, Meattini I, Meduri B, D'angelo E, Dei D, Figlia V, La Rocca E, Fregatti P, Satragno C, Belgioia L, Giaj-Levra N. Fozza A, et al. Expert Rev Anticancer Ther. 2023 Apr;23(4):407-419. doi: 10.1080/14737140.2023.2195167. Epub 2023 Mar 28. Expert Rev Anticancer Ther. 2023. PMID: 36960754 Review.
Radiotherapy in patients with HIV: current issues and review of the literature.
Alongi F, Giaj-Levra N, Sciascia S, Fozza A, Fersino S, Fiorentino A, Mazzola R, Ricchetti F, Buglione M, Buonfrate D, Roccatello D, Ricardi U, Bisoffi Z. Alongi F, et al. Among authors: fozza a. Lancet Oncol. 2017 Jul;18(7):e379-e393. doi: 10.1016/S1470-2045(17)30440-0. Lancet Oncol. 2017. PMID: 28677574 Free article. Review.
Current radiotherapy techniques in NSCLC: challenges and potential solutions.
Giaj-Levra N, Borghetti P, Bruni A, Ciammella P, Cuccia F, Fozza A, Franceschini D, Scotti V, Vagge S, Alongi F. Giaj-Levra N, et al. Among authors: fozza a. Expert Rev Anticancer Ther. 2020 May;20(5):387-402. doi: 10.1080/14737140.2020.1760094. Epub 2020 May 13. Expert Rev Anticancer Ther. 2020. PMID: 32321330 Review.
Choosing the appropriate pharmacotherapy for breast cancer during pregnancy: what needs to be considered?
Favero D, Lapuchesky LS, Poggio F, Nardin S, Perachino M, Arecco L, Scavone G, Ottonello S, Latocca MM, Borea R, Puglisi S, Cosso M, Fozza A, Spinaci S, Lambertini M. Favero D, et al. Among authors: fozza a. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1975-1984. doi: 10.1080/14656566.2023.2293167. Epub 2024 Jan 5. Expert Opin Pharmacother. 2023. PMID: 38179613 Review.
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?
Fozza A, Giaj-Levra N, De Rose F, Ippolito E, Silipigni S, Meduri B, Fiorentino A, Gregucci F, Marino L, Di Grazia A, Cucciarelli F, Borghesi S, De Santis MC, Ciabattoni A. Fozza A, et al. Expert Rev Anticancer Ther. 2021 Aug;21(8):827-840. doi: 10.1080/14737140.2021.1917390. Epub 2021 Apr 25. Expert Rev Anticancer Ther. 2021. PMID: 33852379 Review.
The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer.
Fregatti P, Gipponi M, Atzori G, Rosa R, Diaz R, Cornacchia C, Sparavigna M, Garlaschi A, Belgioia L, Fozza A, Pitto F, Boni L, Blondeaux E, Depaoli F, Murelli F, Franchelli S, Zoppoli G, Lambertini M, Friedman D. Fregatti P, et al. Among authors: fozza a. In Vivo. 2022 Mar-Apr;36(2):814-820. doi: 10.21873/invivo.12768. In Vivo. 2022. PMID: 35241537 Free PMC article.
26 results